Loading clinical trials...
Loading clinical trials...
Outcome of Percutaneous Ethanol Alcohol Injection (PEI) for the Large and Unresectable Hepatocellular Carcinoma.
Conditions
Interventions
Percutaneous ethanol alcohol injection
Locations
1
Sudan
Ribat University Hospital
Khartoum, Sudan
Start Date
May 1, 2017
Primary Completion Date
May 1, 2018
Completion Date
May 30, 2018
Last Updated
May 14, 2019
NCT06707233
NCT05911633
NCT06187961
NCT06561399
NCT04224636
NCT06397222
Lead Sponsor
The National Ribat University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions